184 related articles for article (PubMed ID: 28280366)
1. Salinomycin repressed the epithelial-mesenchymal transition of epithelial ovarian cancer cells via downregulating Wnt/β-catenin pathway.
Li R; Dong T; Hu C; Lu J; Dai J; Liu P
Onco Targets Ther; 2017; 10():1317-1325. PubMed ID: 28280366
[TBL] [Abstract][Full Text] [Related]
2. Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3β/β-catenin/ZEB1 signaling pathway.
Hu C; Dong T; Li R; Lu J; Wei X; Liu P
Oncol Rep; 2016 Apr; 35(4):2027-34. PubMed ID: 26820690
[TBL] [Abstract][Full Text] [Related]
3. Emodin Inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer Cells via ILK/GSK-3
Lu J; Xu Y; Wei X; Zhao Z; Xue J; Liu P
Biomed Res Int; 2016; 2016():6253280. PubMed ID: 28097141
[TBL] [Abstract][Full Text] [Related]
4. CD147 promotes epithelial-mesenchymal transition of prostate cancer cells via the Wnt/β-catenin pathway.
Fang F; Li Q; Wu M; Nie C; Xu H; Wang L
Exp Ther Med; 2020 Oct; 20(4):3154-3160. PubMed ID: 32855684
[TBL] [Abstract][Full Text] [Related]
5. Lidocaine inhibits the proliferation and metastasis of epithelial ovarian cancer through the Wnt/β-catenin pathway.
Sun M; Huang S; Gao Y
Transl Cancer Res; 2021 Jul; 10(7):3479-3490. PubMed ID: 35116652
[TBL] [Abstract][Full Text] [Related]
6. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
[TBL] [Abstract][Full Text] [Related]
7. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
[TBL] [Abstract][Full Text] [Related]
8. Exosome Component 4 Promotes Epithelial Ovarian Cancer Cell Proliferation, Migration, and Invasion
Xiong C; Sun Z; Yu J; Lin Y
Front Oncol; 2021; 11():797968. PubMed ID: 34956910
[TBL] [Abstract][Full Text] [Related]
9. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA CCAT2 promotes epithelial-mesenchymal transition involving Wnt/β-catenin pathway in epithelial ovarian carcinoma cells.
Wang B; Liu M; Zhuang R; Jiang J; Gao J; Wang H; Chen H; Zhang Z; Kuang Y; Li P
Oncol Lett; 2018 Mar; 15(3):3369-3375. PubMed ID: 29435081
[TBL] [Abstract][Full Text] [Related]
11. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
[TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells.
Shan S; Lv Q; Zhao Y; Liu C; Sun Y; Xi K; Xiao J; Li C
Int J Clin Exp Pathol; 2015; 8(10):12357-67. PubMed ID: 26722422
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
Zhuang XH; Liu Y; Li JL
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
[TBL] [Abstract][Full Text] [Related]
15. Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway.
Liu QQ; Chen K; Ye Q; Jiang XH; Sun YW
Cancer Cell Int; 2016; 16():57. PubMed ID: 27453691
[TBL] [Abstract][Full Text] [Related]
16. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
Geng F; Jiang Z; Song X; Zhou H; Zhao H
Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
[TBL] [Abstract][Full Text] [Related]
17. A Theoretical Model of the Wnt Signaling Pathway in the Epithelial Mesenchymal Transition.
Gasior K; Hauck M; Wilson A; Bhattacharya S
Theor Biol Med Model; 2017 Oct; 14(1):19. PubMed ID: 28992816
[TBL] [Abstract][Full Text] [Related]
18. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
[TBL] [Abstract][Full Text] [Related]
19. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
20. LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/beta-catenin signaling pathway.
Xiao C; Wu CH; Hu HZ
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(13):2819-24. PubMed ID: 27424981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
